Ivy P - Search Results

1

A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer.

Stein SM, Tiersten A, Hochster HS, Blank SV, Pothuri B, Curtin J, Shapira I, Levinson B, Ivy P, Joseph B, Guddati AK, Muggia F. Stein SM, et al. Among authors: ivy p. Int J Gynecol Cancer. 2013 Nov;23(9):1577-82. doi: 10.1097/IGC.0b013e3182a809e0. Int J Gynecol Cancer. 2013. PMID: 24172094 Free PMC article. Clinical Trial.

2

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study.

Kuo DY, Blank SV, Christos PJ, Kim M, Caputo TA, Pothuri B, Hershman D, Goldman N, Ivy PS, Runowicz CD, Muggia F, Goldberg GL, Einstein MH. Kuo DY, et al. Gynecol Oncol. 2010 Mar;116(3):442-6. doi: 10.1016/j.ygyno.2009.10.082. Epub 2009 Nov 20. Gynecol Oncol. 2010. PMID: 19931137 Free PMC article. Clinical Trial.

3

Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.

Hochster H, Chen TT, Lu JM, Hills D, Sorich J, Escalon J, Ivy P, Liebes L, Muggia F. Hochster H, et al. Among authors: ivy p. Gynecol Oncol. 2008 Mar;108(3):500-4. doi: 10.1016/j.ygyno.2007.11.017. Epub 2008 Jan 11. Gynecol Oncol. 2008. PMID: 18191187 Free PMC article. Clinical Trial.

4

Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors.

Goel S, Bulgaru A, Hochster H, Wadler S, Zamboni W, Egorin M, Ivy P, Leibes L, Muggia F, Lockwood G, Harvey E, Renshaw G, Mani S. Goel S, et al. Among authors: ivy p. Ann Oncol. 2003 Nov;14(11):1682-7. doi: 10.1093/annonc/mdg453. Ann Oncol. 2003. PMID: 14581279 Free article. Clinical Trial.

5

A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity.

Kobrinsky B, Joseph SO, Muggia F, Liebes L, Beric A, Malankar A, Ivy P, Hochster H. Kobrinsky B, et al. Among authors: ivy p. Cancer Chemother Pharmacol. 2013 Nov;72(5):1073-8. doi: 10.1007/s00280-013-2295-6. Epub 2013 Sep 19. Cancer Chemother Pharmacol. 2013. PMID: 24048674 Clinical Trial.

6

Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors.

McGregor LM, Spunt SL, Santana VM, Stewart CF, Ward DA, Watkins A, Laningham FH, Ivy P, Furman WL, Fouladi M. McGregor LM, et al. Among authors: ivy p. Cancer. 2009 Feb 1;115(3):655-64. doi: 10.1002/cncr.24054. Cancer. 2009. PMID: 19117350 Free PMC article. Clinical Trial.

7

Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study.

McGregor LM, Spunt SL, Furman WL, Stewart CF, Schaiquevich P, Krailo MD, Speights R, Ivy P, Adamson PC, Blaney SM. McGregor LM, et al. Among authors: ivy p. Cancer. 2009 Apr 15;115(8):1765-75. doi: 10.1002/cncr.24175. Cancer. 2009. PMID: 19170226 Free PMC article. Clinical Trial.

8

Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors.

Lam CG, Furman WL, Wang C, Spunt SL, Wu J, Ivy P, Santana VM, McGregor LM. Lam CG, et al. Among authors: ivy p. J Pediatr Hematol Oncol. 2015 Jan;37(1):e13-8. doi: 10.1097/MPH.0000000000000186. J Pediatr Hematol Oncol. 2015. PMID: 24942022 Free PMC article. Clinical Trial.

9

A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.

Liu JF, Tolaney SM, Birrer M, Fleming GF, Buss MK, Dahlberg SE, Lee H, Whalen C, Tyburski K, Winer E, Ivy P, Matulonis UA. Liu JF, et al. Among authors: ivy p. Eur J Cancer. 2013 Sep;49(14):2972-8. doi: 10.1016/j.ejca.2013.05.020. Epub 2013 Jun 27. Eur J Cancer. 2013. PMID: 23810467 Free PMC article. Clinical Trial.

10

Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group.

Takimoto CH, Remick SC, Sharma S, Mani S, Ramanathan RK, Doroshow JH, Hamilton A, Mulkerin D, Graham M, Lockwood GF, Ivy P, Egorin M, Greenslade D, Goetz A, Grem JL. Takimoto CH, et al. Among authors: ivy p. Semin Oncol. 2003 Aug;30(4 Suppl 15):20-5. doi: 10.1016/s0093-7754(03)00401-9. Semin Oncol. 2003. PMID: 14523791 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters